Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -73.75M | -2615.35% | $ 2.82M |
3/31/2025 | $ -59.5M | 0% | $ 0 |
12/31/2024 | $ -57.67M | -357.19% | $ 16.15M |
9/30/2024 | $ -53.64M | -332.19% | $ 16.15M |
6/30/2024 | $ -56.55M | -350.27% | $ 16.15M |
3/31/2024 | $ -64.58M | -399.96% | $ 16.15M |
12/31/2023 | $ -70.71M | 0% | $ 0 |
9/30/2023 | $ -72.84M | 0% | $ 0 |
6/30/2023 | $ -75.82M | 0% | $ 0 |
3/31/2023 | $ -88.5M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for PYXIS ONCOLOGY INC is calculated as follows: CF - Operations [ $ -10.08M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |